- Home
- PHAR vs HNRG Comparison
PHAR vs HNRG Comparison
Compare PHAR & HNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- HNRG
- Stock Information
- Founded
- PHAR 1988
- HNRG 1949
- Country
- PHAR Netherlands
- HNRG United States
- Employees
- PHAR N/A
- HNRG N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- HNRG Coal Mining
- Sector
- PHAR Health Care
- HNRG Energy
- Exchange
- PHAR Nasdaq
- HNRG Nasdaq
- Market Cap
- PHAR 707.9M
- HNRG 664.4M
- IPO Year
- PHAR N/A
- HNRG N/A
- Fundamental
- Price
- PHAR $10.96
- HNRG $16.93
- Analyst Decision
- PHAR Strong Buy
- HNRG Strong Buy
- Analyst Count
- PHAR 3
- HNRG 3
- Target Price
- PHAR $30.00
- HNRG $18.33
- AVG Volume (30 Days)
- PHAR 5.3K
- HNRG 562.2K
- Earning Date
- PHAR 07-31-2025
- HNRG 08-11-2025
- Dividend Yield
- PHAR N/A
- HNRG N/A
- EPS Growth
- PHAR N/A
- HNRG N/A
- EPS
- PHAR N/A
- HNRG N/A
- Revenue
- PHAR $339,836,000.00
- HNRG $410,607,000.00
- Revenue This Year
- PHAR $12.88
- HNRG N/A
- Revenue Next Year
- PHAR $8.54
- HNRG $9.86
- P/E Ratio
- PHAR N/A
- HNRG N/A
- Revenue Growth
- PHAR 22.44
- HNRG N/A
- 52 Week Low
- PHAR $6.73
- HNRG $4.86
- 52 Week High
- PHAR $12.61
- HNRG $19.71
- Technical
- Relative Strength Index (RSI)
- PHAR 58.06
- HNRG 56.33
- Support Level
- PHAR $9.54
- HNRG $16.47
- Resistance Level
- PHAR $10.46
- HNRG $17.80
- Average True Range (ATR)
- PHAR 0.37
- HNRG 0.83
- MACD
- PHAR 0.10
- HNRG 0.16
- Stochastic Oscillator
- PHAR 81.20
- HNRG 70.31
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About HNRG Hallador Energy Company
Hallador Energy Co is a coal mining company with operations in Indiana, USA, and it is part of the electric power generation industry. The operations of the company are divided into two primary reportable segments, the Coal Operations and Electric Operations segments. The majority of revenue is earned from the Coal Operations segment.